Lumen director awarded 25,197 restricted shares
Capossela Christopher C reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Capossela Christopher C reported acquisition or exercise transactions in this Form 4 filing.
Lumen Technologies director Christopher C. Capossela received a grant of 25,197 shares of common stock as a restricted stock award. The grant is valued at $9.44 per share and will vest on May 21, 2027. After this award, he holds 92,199 shares directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 25,197 | $9.44 | $238K |
Footnotes (1)
- F1. This grant of restricted stock will vest on May 21, 2027.
Key Figures
Key Terms
restricted stock financial
vest financial
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Lumen (LUMN) director Christopher Capossela report in this Form 4?
At what price was Christopher Capossela’s Lumen (LUMN) restricted stock grant valued?
Was Christopher Capossela’s Lumen (LUMN) Form 4 a market buy or sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.